Poster

Oligonucleotides for CNS 2025—Optimized Dried Blood Microsampling Extraction Coupled with Hybridization LC-MS/MS for the Sensitive Quantitation of Antisense Oligonucleotides

Oligonucleotides for CNS 2025—Surrogate CSF for the Bioanalysis of Oligonucleotide Therapeutics Through LBA

Strategy for Addressing Specificity Challenges in Quantitation of Etonogestrel in Human Plasma by LC-MS/MS

Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs

Practical Considerations for the Evaluation of Physical Dependence and Drug Withdrawal for Novel CNS-Active Drugs in Clinical Trials

Navigating the Unchartered Territory of Assessing Psychedelics in Human Abuse Potential Studies

Gene Therapy Studies and Germline Integration Assessment in Nonhuman Primates

Geographic Atrophy-Like Induced Model in Nanopigs

Evaluation in Canines of a Novel Device for Suprachoroidal Drug Delivery

Background Data in the Sinclair Nanopig™

Subscribe to Poster